Clinical Research Directory
Browse clinical research sites, groups, and studies.
RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
Sponsor: Fudan University
Summary
This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that requires adjuvant radiotherapy to increase local control rate, excluding undifferentiated cancer. Local-regional recurrence free survival is the primary endpoint of the study.
Official title: A Real-world Study of Adjuvant Radiotherapy in High Recurrence Risk Locally Advanced Thyroid Cancer
Key Details
Gender
All
Age Range
14 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2024-07-02
Completion Date
2031-06-30
Last Updated
2026-02-27
Healthy Volunteers
No
Conditions
Interventions
adjuvant radiotherapy
The patients would receive external radiation therapy within 6 weeks after surgery, using intensity-modulated radiation therapy (IMRT) or volume modulated radiation therapy (VMAT) techniques. 6MV-X-ray irradiation. Conventional segmented irradiation is used, once a day, five times a week, with a segmented dose of 2Gy per dose.
Locations (1)
Fudan University Shanghai Cancer Center
Shanghai, China